Saba Capital Management Amends abrdn Healthcare Investors Filing
Ticker: HQH · Form: SC 13D/A · Filed: Nov 18, 2024 · CIK: 805267
| Field | Detail |
|---|---|
| Company | Abrdn Healthcare Investors (HQH) |
| Form Type | SC 13D/A |
| Filed Date | Nov 18, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.01, $41,285,158 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 13D-filing, ownership-change, activist-investor
TL;DR
Saba Capital updated its abrdn Healthcare Investors stake filing on 11/18/24.
AI Summary
Saba Capital Management, L.P. has amended its Schedule 13D filing regarding abrdn Healthcare Investors, as of November 18, 2024. The filing indicates a change in the beneficial ownership of the common shares of abrdn Healthcare Investors. Saba Capital Management, L.P. is listed as the filer, with its business address in New York.
Why It Matters
This amendment to a Schedule 13D filing signals potential shifts in significant ownership stakes, which can influence stock price and corporate strategy.
Risk Assessment
Risk Level: medium — Schedule 13D filings often indicate significant investor activity, which can lead to volatility.
Key Players & Entities
- Saba Capital Management, L.P. (company) — Filer of the Schedule 13D/A
- abrdn Healthcare Investors (company) — Subject company of the filing
- BOAZ R. WEINSTEIN (person) — Group member associated with the filing
- SABA CAPITAL MANAGEMENT GP, LLC (company) — Group member associated with the filing
FAQ
What is the filing type and amendment number?
The filing type is SC 13D/A, and it is Amendment No. 3.
Who is the subject company?
The subject company is abrdn Healthcare Investors.
Who is the entity filing the Schedule 13D/A?
Saba Capital Management, L.P. is the entity filing the Schedule 13D/A.
What is the CUSIP number for abrdn Healthcare Investors' common shares?
The CUSIP number is 87911J103.
What is the filing date of this amendment?
The filing date is November 18, 2024.
Filing Stats: 1,345 words · 5 min read · ~4 pages · Grade level 11 · Accepted 2024-11-18 16:02:58
Key Financial Figures
- $0.01 — tors (Name of Issuer) Common Shares, $0.01 par value (Title of Class of Securiti
- $41,285,158 — ported herein. A total of approximately $41,285,158 was paid to acquire the Common Shares r
Filing Documents
- formsc13da.htm (SC 13D/A) — 66KB
- 0001062993-24-019263.txt ( ) — 68KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: November 18, 2024 SABA CAPITAL MANAGEMENT, L.P. By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Chief Compliance Officer SABA CAPITAL MANAGEMENT GP, LLC By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Authorized Signatory BOAZ R. WEINSTEIN By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Attorney-in-fact* * Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823 CUSIP No. 87911J103 SCHEDULE 13D/A Page 7 of 7 Pages Schedule A This Schedule sets forth information with respect to each purchase and sale of Common Shares which were effectuated by Saba Capital since the filing of the Schedule 13D/A on 10/22/24. All transactions were effectuated in the open market through a broker. Trade Date Buy/Sell Shares Price 10/22/2024 Sell 34,789 18.58 10/23/2024 Sell 8,296 18.47 10/25/2024 Sell 3,038 18.41 10/28/2024 Sell 5,215 18.43 10/30/2024 Sell 200 18.34 11/4/2024 Sell 5,291 18.26 11/5/2024 Sell 15,244 18.19 11/6/2024 Sell 5,329 18.46 11/11/2024 Sell 45,773 18.73 11/12/2024 Sell 13,487 18.65 11/13/2024 Sell 900 18.45 11/14/2024 Sell 13,656 18.08 11/15/2024 Sell 6,835 17.40